Effectiveness of serological markers of gastric mucosal atrophy in the gastric precancer screening and in cancer prevention

Table 5 Morphological structure of intestinal metaplasia and dysplasia

IM specification	Patients, n	Intestinal metaplasia quota, %
None	74	43.8	43.8
Mild	42	24.8	56.2
Moderate	35	20.7
Severe	18	10.7
Total	169	100	100
Dysplasia specification	Patients, n	Dysplasia quota, %
None	85	50.3	50.3
Mild	36	21.4	49.7
Moderate	42	24.8
Severe	6	3.5
Total	169	100	100

IM: Intestinal metaplasia.